Human Pluripotent Stem Cells for the Treatment of Type 1 Diabetes

Human Pluripotent Stem Cells for the Treatment of Type 1 Diabetes | Recording

Overview

The webcast presents the state of the art of using iPSCs for the treatment of type 1 diabetes. The learning objectives of this webinar includes: to learn the state of the art of using iPSC for the treatment of T1D and to learn the current status of using iPSCs to develop TID disease models or for candidate drug screening.

Speakers and Moderators

Speakers:
Douglas Melton, PhD
Professor, Distinguished Research Fellow Vertex Cell and Gene Therapies

Shuibing Chen, PhD
Kilts Family Professor & Vice Chair of Innovation Department of Surgery, Director of Center of Genomic Health Weill Cornell Medicine

Moderators:
Hongjun Wang, PhD
Professor, Medical University of South Carolina

Jeffery S. Tessem, PhD
Associate Professor of Nutritional Science Department of Nutrition, Dietetics and Food Science, Brigham Young University

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	No Credit Offered

Create Account